NWRD08
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NWRD08, covering 2026-02-17 to 2026-02-17. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of NWRD08 for HPV-16 and/or HPV-18 Related Cervical HSIL [Phase 2]